Ascletis Pharma Stock Probability of Future Pink Sheet Price Finishing Over 3.90
| ASCLF Stock | USD 0.18 0.01 5.26% |
Ascletis |
Ascletis Pharma Target Price Odds to finish over 3.90
The tendency of Ascletis Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 3.90 or more in 90 days |
| 0.18 | 90 days | 3.90 | close to zero percent |
Based on a normal probability distribution, the odds of Ascletis Pharma to move over $ 3.90 or more in 90 days from now is close to zero percent (This Ascletis Pharma probability density function shows the probability of Ascletis Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Ascletis Pharma price to stay between its current price of $ 0.18 and $ 3.90 at the end of the 90-day period is about 26.73 .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.82 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ascletis Pharma will likely underperform. Additionally Ascletis Pharma has an alpha of 0.0976, implying that it can generate a 0.0976 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ascletis Pharma Price Density |
| Price |
Predictive Modules for Ascletis Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascletis Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ascletis Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ascletis Pharma is not an exception. The market had few large corrections towards the Ascletis Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ascletis Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ascletis Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.1 | |
β | Beta against Dow Jones | 1.82 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.06 |
Ascletis Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascletis Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascletis Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ascletis Pharma has some characteristics of a very speculative penny stock | |
| Ascletis Pharma had very high historical volatility over the last 90 days | |
| Ascletis Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 76.88 M. Net Loss for the year was (199.02 M) with profit before overhead, payroll, taxes, and interest of 39.17 M. | |
| Ascletis Pharma has accumulated about 2.5 B in cash with (146.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 67.0% of the company shares are held by company insiders |
Ascletis Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ascletis Pink Sheet often depends not only on the future outlook of the current and potential Ascletis Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascletis Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 B |
Ascletis Pharma Technical Analysis
Ascletis Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ascletis Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascletis Pharma. In general, you should focus on analyzing Ascletis Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Ascletis Pharma Predictive Forecast Models
Ascletis Pharma's time-series forecasting models is one of many Ascletis Pharma's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ascletis Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Ascletis Pharma
Checking the ongoing alerts about Ascletis Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ascletis Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ascletis Pharma has some characteristics of a very speculative penny stock | |
| Ascletis Pharma had very high historical volatility over the last 90 days | |
| Ascletis Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 76.88 M. Net Loss for the year was (199.02 M) with profit before overhead, payroll, taxes, and interest of 39.17 M. | |
| Ascletis Pharma has accumulated about 2.5 B in cash with (146.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 67.0% of the company shares are held by company insiders |
Other Information on Investing in Ascletis Pink Sheet
Ascletis Pharma financial ratios help investors to determine whether Ascletis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ascletis with respect to the benefits of owning Ascletis Pharma security.